The Reproductive Health Supplies Visualizer (RH Viz) is a series of public-facing dashboards designed to help the RH community see integrated and aggregated supply chain inventory, order, and shipment data.

The Global Family Planning Visibility and Analytics Network (VAN) captures data from multiple sources to improve supply chain visibility. The VAN offers a platform to assess supply needs, prioritize them, and act when supply imbalances loom.

This is an open-access collection of health market literature, featuring documents and related resources needed to understand, develop, and intervene in different global health markets.

This press release announces the price reduction of Sayana Press from $1 to $0.85 per dose in qualifying countries.

This thesis provides an in-depth review of key World Health Organization-led procedures for registering medicines in developing countries, including prequalification, the concept of essential medicines, and collaborative registration.

A concise summary of WHO’s Collaborative Registration Procedure describes the advantages of this program as well as experiences and lessons learned during the launch of this activity in 2012.

This guide provides direction to programs that want to forecast for new and underused methods (NUMs) of family planning. It supports program managers and others involved in forecasting as they plan to introduce a contraceptive technology for the first time in a country and/or position an underused method for scale-up.

This progress report summarizes the work of the DMPA-SC Consortium, a group of public, private, and philanthropic entities that coordinate global support for scale up of DMPA-SC as a contraceptive option.

The Reproductive Health Supplies Coalition (RHSC) is a global partnership of public, private, and non-governmental organizations dedicated to ensuring that all people in low- and middle-income countries can access and use affordable, high-quality supplies to ensure their better reproductive health. The Coalition brings together diverse agencies and groups with critical roles in providing contraceptives and other reproductive health supplies. These include multilateral and bilateral organizations, private foundations, governments, civil society, and private-sector representatives.

This 16-page paper provides an overview of the debate about how developing country drug regulation agencies are funded and the extent to which they should build local capacity or rely on regulators in developed countries.